Your browser doesn't support javascript.
loading
SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models.
Gray, Elizabeth; Ulrich, Michelle; Epp, Angela; Younan, Patrick; Sahetya, Disha; Hensley, Kelly; Allred, Sean; Huang, Li-Ya; Hahn, Julie; Gahnberg, Kristen; Treuting, Piper M; Trueblood, Esther S; Gosink, John J; Thurman, Robert; Wo, Serena; Spahr, Kellie; Haass, Evgenia Jane; Snead, Katie; Miller, Dannah; Padilla, Mary; Smith, Alyson J; Frantz, Chris; Schrum, Jason P; Nazarenko, Natalya; Gardai, Shyra J.
Afiliação
  • Gray E; Seagen Inc, Bothell, Washington, USA egray@seagen.com.
  • Ulrich M; Seagen Inc, Bothell, Washington, USA.
  • Epp A; Seagen Inc, Bothell, Washington, USA.
  • Younan P; Seagen Inc, Bothell, Washington, USA.
  • Sahetya D; Seagen Inc, Bothell, Washington, USA.
  • Hensley K; Seagen Inc, Bothell, Washington, USA.
  • Allred S; Seagen Inc, Bothell, Washington, USA.
  • Huang LY; Seagen Inc, Bothell, Washington, USA.
  • Hahn J; Seagen Inc, Bothell, Washington, USA.
  • Gahnberg K; Seagen Inc, Bothell, Washington, USA.
  • Treuting PM; Seagen Inc, Bothell, Washington, USA.
  • Trueblood ES; Seagen Inc, Bothell, Washington, USA.
  • Gosink JJ; Seagen Inc, Bothell, Washington, USA.
  • Thurman R; Seagen Inc, Bothell, Washington, USA.
  • Wo S; Seagen Inc, Bothell, Washington, USA.
  • Spahr K; Seagen Inc, Bothell, Washington, USA.
  • Haass EJ; Seagen Inc, Bothell, Washington, USA.
  • Snead K; Seagen Inc, Bothell, Washington, USA.
  • Miller D; Seagen Inc, Bothell, Washington, USA.
  • Padilla M; Seagen Inc, Bothell, Washington, USA.
  • Smith AJ; Seagen Inc, Bothell, Washington, USA.
  • Frantz C; Seagen Inc, Bothell, Washington, USA.
  • Schrum JP; Seagen Inc, Bothell, Washington, USA.
  • Nazarenko N; Seagen Inc, Bothell, Washington, USA.
  • Gardai SJ; Seagen Inc, Bothell, Washington, USA.
J Immunother Cancer ; 11(10)2023 10.
Article em En | MEDLINE | ID: mdl-37793853

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Antineoplásicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos